| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |